You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ATTO Conversion Disclosure
Frazier Life Sciences Xi, L.P. · SEC Form 4 · Filed Aug 6, 2026
Conversion
Calculated transaction value
$0
Frazier Life Sciences Xi, L.P. 10% owner
ATTO
Transaction date
Aug 6, 2026
Public filing date
Aug 6, 2026
Filing lag
Filed same day
ATTO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series B Preferred Stock on Common Stock
- Quantity / price
- 11,054,544 shares @ $0
- SEC ownership
- Direct
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0001231919-26-000838
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$10M
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | Not reported |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO Current | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | $0 |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | Not reported |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | Not reported |
| Attovia Therapeutics, Inc. ATTO | Buy | Aug 6, 2026 | $10M |
| Attovia Therapeutics, Inc. ATTO | Conversion | Aug 6, 2026 | Not reported |